Mehdi NajafZadeh, PhD is a real-world evidence (RWE) strategist and pharmacoepidemiologist with over 15 years of experience generating regulatory- and HTA-grade evidence across rare disease, autoimmune, oncology, and cardio-metabolic therapeutic areas.
As a former Assistant Professor and Principal Investigator at Brigham and Women's Hospital, Harvard Medical School, Mehdi led NIH and FDA-funded research, developing methods for trial–RWD linkage, generalizing trial results to target real-world populations, target trial emulation, causal inference, and health economics and outcomes research (HEOR). He subsequently served as Senior Director of Evidence Generation at Medidata AI, advising biopharma partners on integrated evidence plans, data linkage, and clinical data strategy.
Mehdi has authored 70+ peer-reviewed publications in journals including NEJM, Annals of Internal Medicine, and JAMA Network Open, and is a frequent speaker and session chair at ISPOR, DIA, and ICPE. He founded Qubit Data to bring this depth of scientific expertise directly to biopharma teams navigating complex evidence challenges.